Sofwave is the latest technology to revitalize skin by addressing fine lines and wrinkles through innovative stimulation of the production of new collagen.
- Totally non-invasive, with minimal pain or downtime
- Typically only 1 or 2 treatments required
- Quick, with treatment for the full face taking 40 minutes
- Results typcially seen after a week and continue to improve with time
- Suitable for all skin types and for the full face
- Amazing eye lifting results - up to 4mm lift!
Call 020 7460 7324
Schedule A Complimentary Consultation With Dr Rita Rakus
what is sofwave?
Sofwave is an FDA approved non-invasive treatment of fine lines and wrinkles which uses a next generation SUPERB™ Synchronous Ultrasound Parallel Beam Technology designed to minimize downtime and optimize patient convenience. The fractional heating effect created by Sofwave’s unique ultrasound delivery stimulates the production of new collagen and elastin, which leads to the reduction in fine lines and wrinkles.
Sofwave’s unique technology enables the controlled delivery of energy, in terms of amount and location, while protecting the skin surface with an integrated cooling mechanism Sofcool™ to minimize downtime and any interruption to your daily routine.
What areas does Sofwave treat?
Sofwave can be used on the full face to target fine lines and wrinkles and give a total facial rejuvenation. It is Dr Rita's favourite treatment for the eye area - Sofwave can give amazing results with an up to 4mm eye lift!
When can you expect to see results?
Sofwave is a highly effective treatment that can deliver visible results in a single treatment, which typically takes just 30-45 minutes. Usually after 1 week you can start to really see the difference and as the collagen regenerates results will continute to improve over a period of 12 weeks, with the skin becoming smoother, tighter and lifted.
How many treatments do you need?
Typically a patient will require 1 - 2 Sofwave treatment sessions, depending on the patient, their skin condition and the desired results.